Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures


Published: 10 April 2020
Abstract Views: 22779
PDF: 11220
HTML: 34
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Giovanni Ricevuti Department of Drug Science, University of Pavia, Italy, High School in Oxygen Ozone Therapy, University of Pavia, Italy.
  • Marianno Franzini SIOOT International, Comunian Clinic, Gorle (BG); High School in Oxygen Ozone Therapy, University of Pavia, Italy.
  • Luigi Valdenassi SIOOT, Italian Society of Oxygen Ozone Therapy, High School in Oxygen Ozone Therapy, University of Pavia, Italy, Italy.

The problems related to the approach to the outbreak of COVID-19 in the world require that all possible effective treatment options be explored. The clinical criterion of the researcher is not to refuse a priori, but to verify and evaluate the proposals that are made. Italian Society of Oxygen Ozone Therapy (SIOOT) proposed to the Italian ISS (Italian Institute of Health) to use oxygen ozone therapy (O2O3) in patients with COVID-19. (...)


Ricevuti, G., Franzini, M., & Valdenassi, L. (2020). Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Therapy, 5(1). https://doi.org/10.4081/ozone.2020.9014

Downloads

Download data is not yet available.

Citations